| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $988.0M | +1.5% | +10.3% |
| Gross Profit | $461.0M | +1.8% | +6.7% |
| R&D Expense | $76.0M | +0.0% | +8.6% |
| SG&A Expense | $180.0M | +2.9% | +7.8% |
| Operating Income | $138.0M | +2.2% | +7.8% |
| Interest Expense | $53.0M | -3.6% | -17.2% |
| Pre-tax Income | $84.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $413.0M | -17.1% | -5.9% |
| Accounts Receivable | $611.0M | -5.9% | +0.3% |
| Inventory | $934.0M | +1.7% | -0.6% |
| Current Assets | $2.54B | +2.1% | -4.9% |
| Total Assets | $8.78B | -0.6% | -2.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $503.0M | — | — |
| Capital Expenditures | $98.0M | — | — |
| Investing Cash Flow | -$96.0M | — | — |
| Financing Cash Flow | -$437.0M | — | — |
| Free Cash Flow | $405.0M | — | — |
| +16.7% |
| +40.0% |
| Income Tax | $10.0M | +0.0% | +600.0% |
| Net Income | $74.0M | +19.4% | +19.4% |
| EPS (Basic) | $1.10 | +19.6% | +19.6% |
| EPS (Diluted) | $1.10 | +19.6% | +19.6% |
| $886.0M |
| +6.5% |
| +13.4% |
| Long-term Debt | $4.25B | -2.4% | -10.6% |
| Total Liabilities | $6.18B | -1.5% | -6.8% |
| Stockholders' Equity | $2.60B | +1.8% | +8.4% |